Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Neurologic Clinics|March 29, 2011
Treatment of multiple sclerosis exacerbationsPavle Repovic, Fred D Lublin
Continuum (Minneapolis, Minn.)|June 5, 2019
Management of Multiple Sclerosis RelapsesPavle Repovic
European Journal of Neurology|December 20, 2021
Early first-line treatment response and subsequent disability worsening in relapsing-remitting multiple sclerosisMarcus W Koch, Jop Mostert, Pavle Repovic, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 5, 2002
Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microgliaPavle Repovic, Etty N Benveniste
European Neurology|October 4, 2014
New multiple sclerosis phenotypic classificationFred D Lublin
Journal of the Neurological Sciences|March 6, 2007
The incomplete nature of multiple sclerosis relapse resolutionFred D Lublin
Journal of the Neurological Sciences|April 13, 2013
MS as a gateway diseaseFred D Lublin
Current Opinion in Neurology|June 5, 2002
The diagnosis of multiple sclerosisFred D Lublin
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2023
Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx datasetMarcus W Koch, Ester Moral, Luis Brieva, et al.
Glia|May 6, 2003
Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharidePavle Repovic, Kaihong Mi, Etty N Benveniste
Pageof 13